Wuhan humanwell likang pharmaceutical co.,ltd

News Center
您现在的位置:
Homepage
/
/
/
Guangming.com: Hubei Huahua breaks through the development of big health industry

Information

Guangming.com: Hubei Huahua breaks through the development of big health industry

(Summary description)"This is not only a need, but also a development trend that is'ready to emerge'." On July 7, Yuan Defang, deputy director of the Hubei Provincial Development and Reform Commission, introduced at a special press conference that after Hubei Province has achieved decisive results in epidemic prevention and control, the province The provincial government quickly researched and put forward a "Hubei model" for the reform of the disease prevention and control system and the construction of the public health system, emphasized the establishment of the concept of "big health", and proposed breakthroughs in the development of the big health industry.

Guangming.com: Hubei Huahua breaks through the development of big health industry

(Summary description)"This is not only a need, but also a development trend that is'ready to emerge'." On July 7, Yuan Defang, deputy director of the Hubei Provincial Development and Reform Commission, introduced at a special press conference that after Hubei Province has achieved decisive results in epidemic prevention and control, the province The provincial government quickly researched and put forward a "Hubei model" for the reform of the disease prevention and control system and the construction of the public health system, emphasized the establishment of the concept of "big health", and proposed breakthroughs in the development of the big health industry.

Information
  "This is not only a need, but also a development trend that is'ready to emerge'." On July 7, Yuan Defang, deputy director of the Hubei Provincial Development and Reform Commission, introduced at a special press conference that after Hubei Province has achieved decisive results in epidemic prevention and control, the province The provincial government quickly researched and put forward a "Hubei model" for the reform of the disease prevention and control system and the construction of the public health system, emphasized the establishment of the concept of "big health", and proposed breakthroughs in the development of the big health industry.
 
   Hubei, who has undergone a "people first, life first" epidemic prevention and control test, knows that it is necessary to treat the disease before and before it. Not only must the "visible hand" reform and improve the public health and disease control system, but also the "invisible hand" must be used to develop the big health industry. Recently, Hubei issued the "Several Opinions on Accelerating the Development of Hubei Province's Big Health Industry", clarifying ten major tasks such as joint research and development of antiviral drugs, import substitution of high-end medical equipment, and accelerating the development of industrial clusters. "Fast forward button", striving to escape the "acceleration" of the development of the big health industry.
 
  At present, the scale of Hubei Province's large-scale health industry has exceeded 450 billion yuan, and a large-scale health industry system that radiates medical and health services, pharmaceutical manufacturing and sales, health care, leisure and health, and healthy sports has basically taken shape.
 
   In the war against the epidemic, batches of companies that have been deeply involved in the field of health have taken the lead in ensuring the supply of prevention and control materials, front-line assistance to fight the epidemic, and taking on social responsibilities. They not only guarded everyone's comprehensiveness, but also magnified corporate value.
 
   In the East Lake High-tech Zone, a large number of "unstoppable" companies have achieved explosive growth. The international order volume of BGI's new crown virus detection kit exceeds 10 million people, covering more than 80 countries and regions around the world; AutoNavi Infrared independently developed infrared temperature measurement equipment, which has been widely used in various scenarios of epidemic prevention and control. Substantial growth. Companies such as Mingde Biotech and Huakang Century performed outstandingly during the epidemic, and some products related to the detection of new crown virus obtained foreign access permits.
 
   The new crown pneumonia epidemic is a test for companies in the big health industry, and it has also given birth to new opportunities. Renfu Pharmaceutical Group Co., Ltd., headquartered in Optics Valley Bio-city, gave its own answer.
 
   The supply chain was interrupted, the raw materials were in a hurry, and the logistics cost of air transportation increased... After the outbreak, Renfu Puke Pharmaceutical (Wuhan) Co., Ltd., a subsidiary of Renfu Medicine, faced many challenges. Every second counts and rises to difficulties. Currently, Renfoppke's 9 production lines are fully operational, producing more than 1.3 billion soft capsules for export. Compared with the same period in history, new growth has been achieved.
 
“In the past, we only paid attention to the operation status of enterprises in the adjacent industrial chain related to enterprises. Affected by the epidemic, we innovated the forward-delayed management method of cooperation with enterprises in the industrial chain. After the epidemic, it is no longer a single-line control and people-oriented approach. Management, but to extend the tentacles and warm up with our upstream suppliers to form an altruistic atmosphere and values.” In the view of An Yonghong, the executive deputy general manager of Renfolk, the product structure should be extended and innovated. Some echelon supplements and transformations of drugs and generic drugs may be the new development direction brought to enterprises by the epidemic.
 
   A global spread of the new crown pneumonia epidemic not only reminds us to actively build a new pattern of domestic and international mutual promotion, but also shows the necessity and urgency of the people of the world to join hands in building a human health community.
 
   I know the pines and cypresses in the cold, and see the true love in adversity. Renfu Africa Pharmaceutical Co., Ltd., a subsidiary of Renfu Medicine, did not stop work and production at the most difficult moment in Mali's fight against the new crown pneumonia epidemic. Instead, it did its best to produce 6 million bottles for Mali, Burkina Faso, Senegal and other West African countries. Infusion and 2 million bottles of syrup provided a large number of basic medicines for Mali and West Africa.
 
  The person in charge of Renfu Medicine said that after this "epidemic", Renfu Medicine, which adheres to the development concept of "Let the Tree of Life Evergreen", will more firmly focus on the main business of medicine, and cooperate with scientific research institutes to develop more new drugs to protect the health of the people. . At the same time, speed up the internationalization strategy, transform and upgrade the production line, let more drugs pass international certification, obtain international approval, and contribute to the creation of a human health community. (Zhang Rui, all media reporter of Guangming Daily)

Scan the QR code to read on your phone

Message

WRITE A MESSAGE TO US

Username used for comment:
Client messages
Description:
验证码

Hot News

imgboxbg

Corporate Culture

Make the drug market safer and faster, and make the tree of life evergreen

TOP

CONTACT US

Business customer service

Personnel administration

Telephone:027-86506632-8888
E-mail:hr@likang-pharma.com

Address: No.98 shendun 2nd Road, Donghu New Technology Development Zone, Wuhan

Official wechat

  Wuhan humanwell likang pharmaceutical co.,ltd

Share

Copyright:Wuhan humanwell likang pharmaceutical co.,ltd  Powered by www.300.cn  鄂ICP备20013524号-2